Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

and evolution experiments on revealed several principles of bacterial adaptation. However, few data are available in the literature describing the behavior of in its natural environment. We attempted here to study the evolution in the human gut of a commensal dominant clone, ED1a belonging to the B2 phylogroup, through a longitudinal genomic study. We sequenced 24 isolates sampled at three different time points within a healthy individual over almost a year. We computed a mutation rate of 6.90 × 10 mutations per base per year of the chromosome for ED1a in healthy human gut. We observed very limited genomic diversity and could not detect any evidence of selection, in contrast to what is observed in experimental evolution over a similar length of time. We therefore suggest that ED1a, being well adapted to the healthy human gut, evolves mostly neutrally with a low effective population size ( of ≈500 to 1,700). In this study, we follow the genomic fate of a dominant clone of in the human gut of a healthy individual over about a year. We could compute a low annual mutation rate that supports low diversity, and we could not retrieve any clear signature of selection. These observations support a neutral evolution of in the human gut, compatible with a very limited effective population size that deviates drastically with the observations made previously in experimental evolution.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835743PMC
http://dx.doi.org/10.1128/AEM.02377-17DOI Listing

Publication Analysis

Top Keywords

human gut
24
effective population
12
population size
12
neutral evolution
8
evolution human
8
dominant clone
8
healthy individual
8
individual year
8
mutation rate
8
healthy human
8

Similar Publications

Ciprofloxacin (CIP), a widely used fluoroquinolone antibiotic, has become a significant contaminant in aquatic environments due to its extensive use and incomplete metabolism. This review comprehensively analyses CIP pollution, including its sources, environmental and health impacts, and removal strategies. Chemical methods such as advanced oxidation processes and physical techniques like adsorption are evaluated for their efficiency in CIP removal.

View Article and Find Full Text PDF

Although dynamical systems models are a powerful tool for analysing microbial ecosystems, challenges in learning these models from complex microbiome datasets and interpreting their outputs limit use. We introduce the Microbial Dynamical Systems Inference Engine 2 (MDSINE2), a Bayesian method that learns compact and interpretable ecosystems-scale dynamical systems models from microbiome timeseries data. Microbial dynamics are modelled as stochastic processes driven by interaction modules, or groups of microbes with similar interaction structure and responses to perturbations, and additionally, noise characteristics of data are modelled.

View Article and Find Full Text PDF

The maternal microbiome during pregnancy and the peripartum period plays a critical role in maternal health outcomes and establishing the neonatal gut microbiome, with long-term implications for offspring health. However, a healthy microbiome during these key periods has not been definitively characterized. This longitudinal study examines maternal and neonatal microbiomes using 16S rRNA amplicon sequencing in a Japanese cohort throughout pregnancy and the postpartum period.

View Article and Find Full Text PDF

Amphetamines are psychostimulants that are commonly used to treat neuropsychiatric disorders and are prone to misuse. The pathogenesis of amphetamine use disorder (AUD) is associated with dysbiosis (an imbalance in the body's microbiome) and bacterially produced short-chain fatty acids (SCFAs), which are implicated in the gut-brain axis. Amphetamine exposure in both rats and humans increases the amount of intestinal , which releases SFCAs.

View Article and Find Full Text PDF

Sickness-induced sleep is a behavior conserved across species that promotes recovery from illness, yet the underlying mechanisms are poorly understood. Here, we show that interleukin-6-like cytokine signaling from the gut to brain glial cells regulates sleep. Under healthy conditions, this pathway promotes wakefulness.

View Article and Find Full Text PDF